Memphis, TN, United States of America

Michael L Mohler

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.1

ph-index = 4

Forward Citations = 43(Granted Patents)


Location History:

  • Cordova, TN (US) (2007 - 2010)
  • Memphis, TN (US) (2012 - 2016)

Company Filing History:


Years Active: 2007-2016

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Michael L Mohler: Innovator in Nuclear Receptor Binding Agents

Introduction

Michael L Mohler is a prominent inventor based in Memphis, TN (US). He has made significant contributions to the field of nuclear receptor binding agents, holding a total of 7 patents. His work focuses on developing innovative solutions for various health-related issues.

Latest Patents

Among his latest patents, Mohler has developed compounds related to estrogen receptor ligands and methods of use thereof. These novel nuclear receptor binding agents (NRBAs) are designed for the prevention and treatment of a variety of diseases and conditions. This includes hormone-related diseases, cancers, inflammation, osteoporosis, peripheral vascular disease, and cardiovascular disease. His research also addresses the prevention and treatment of cancers such as prostate and breast cancer, as well as neurological disorders and obesity.

Career Highlights

Throughout his career, Mohler has worked with notable organizations, including GTx Corporation and the University of Tennessee Research Foundation. His expertise in the field has led to advancements in medical treatments and therapies.

Collaborations

Some of his notable coworkers include Duane Douglas Miller and James T Dalton. Their collaborative efforts have contributed to the success of Mohler's innovative projects.

Conclusion

Michael L Mohler's work in nuclear receptor binding agents showcases his dedication to advancing medical science. His patents reflect a commitment to addressing critical health issues through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…